HLA Class II Alleles and Suicidal Behavior: Evidence from a Case–Control Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010181 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mihaela Elvira Cîmpianu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Iuliu Haṭieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Alleles, HLA-DQ beta-Chains, HLA-DRB1 Chains, Suicide. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, "1st December 1918" University of Alba Iulia, Alba Iulia, Romania, University of Alba Iulia, Alba Iulia, Romania.
Abstract (Originalsprache)
Suicidality is a complex multifactorial phenomenon strongly associated with major depression and other psychiatric disorders. Building on evidence implicating the Major Histocompatibility Complex (MHC) in modulating the immune and inflammatory processes characterizing psychiatric disorders, we hypothesized that specific HLA-DQB1 and HLA-DRB1 variants may contribute to an increased genetic susceptibility to suicidal behavior. Human Leucocyte Antigen (HLA) typing by sequence-specific primers (PCR-SSP) was performed on a sample of 196 individuals, including 70 non-lethal suicide attempters, 28 cases of completed suicide, and matched controls. The *HLA-DQB1 02/06 (RR 1.60, CI95% 1.22–2.09, p = 0.03 *) and *HLA-DRB1 11/15 (RR 1.70, CI95% 1.3–2.24, p = 0.04 *) genotypes and the HLA-DRB115~DQB103 haplotype (RR 1.58, CI95% 1.22–2.04, p = 0.03 *) were found to favor suicidal behavior. Psychosocial determinants associated with an increased suicidal risk were bereavement of close relatives (linked with HLA-DQB1*02), memory dysfunction (HLA-DQB1*06), disillusionment (HLA-DRB1*07 and HLA-DRB1*15), and self-harm (HLA-DRB1*15). Our findings support the contributory role of HLA polymorphisms in shaping susceptibility to suicidal behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Biology, Iuliu Haṭieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
- Department of Social Sciences, "1st December 1918" University of Alba Iulia, 510009 Alba Iulia, Romania.
- Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
- Faculty of Medicine, Iuliu Haṭieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
- Faculty of Sociology and Social Work, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania.
- Romanian Institute for Evaluation and Strategy-IRES, 400495 Cluj-Napoca, Romania.
ORCID-Profile: Mihaela Elvira Cîmpianu, Mihaela Laura Vică Matei, Costel Vasile Siserman
Förderung
- Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
- "1st December 1918" University of Alba Iulia, Alba Iulia, Romania
- University of Alba Iulia, Alba Iulia, Romania
Zitieren
APA
Cîmpianu, M. E., Vică Matei, M. L., Bâlici, Ș., Nicula, G. Z., Domșa, E. M., Cîmpianu, T., Rusu, S. I., Coman, H. G., & Siserman, C. V. (2025). HLA Class II Alleles and Suicidal Behavior: Evidence from a Case–Control Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010181
Vancouver
Cîmpianu ME, Vică Matei ML, Bâlici Ș, Nicula GZ, Domșa EM, Cîmpianu T, et al. HLA Class II Alleles and Suicidal Behavior: Evidence from a Case–Control Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010181
BibTeX
@article{Cmpianu2025,
author = {Cîmpianu, Mihaela Elvira and Vică Matei, Mihaela Laura and Bâlici, Ștefana and Nicula, Gheorghe Zsolt and Domșa, Elena Maria and Cîmpianu, Teodora and Rusu, Sergiu Ionica and Coman, Horia George and Siserman, Costel Vasile},
title = {HLA Class II Alleles and Suicidal Behavior: Evidence from a Case–Control Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010181}
}
EUVIMED